0001325812-16-000078.txt : 20160203
0001325812-16-000078.hdr.sgml : 20160203
20160203173417
ACCESSION NUMBER: 0001325812-16-000078
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160201
FILED AS OF DATE: 20160203
DATE AS OF CHANGE: 20160203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001178670
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770602661
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (617) 551-8200
MAIL ADDRESS:
STREET 1: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20020724
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mason Michael
CENTRAL INDEX KEY: 0001514291
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36407
FILM NUMBER: 161385986
MAIL ADDRESS:
STREET 1: 300 3RD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2016-02-01
0
0001178670
ALNYLAM PHARMACEUTICALS, INC.
ALNY
0001514291
Mason Michael
300 THIRD STREET
CAMBRIDGE
MA
02142
0
1
0
0
VP, Finance and Treasurer
Performance Stock Option 2014 (right to buy)
96.45
2016-02-01
4
A
0
2750.0
0.0
A
2016-02-01
2024-12-17
Common Stock
2750
2750
D
On December 17, 2014, the reporting person was granted a performance based stock option to purchase shares of ALNY Common Stock. One-third of the shares subject to the option will vest upon the achievement of each of three specific clinical development and regulatory events, as approved by our compensation committee. Effective February 1, 2016, the compensation committee of the Company determined the first performance criteria had been met and the option vested as to one-third of the shares.
Michael P Mason
2016-02-03